CLASS II Drug recall · Reported 15 Jun 2022 · FDA Enforcement Report

Earache Drops recalled by Grato Holdings

Grato Holdings is recalling Earache Drops, distributed nationwide in the US. The recall was initiated on 24 May 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: G11639, Exp. Date 09/24
NDC0363-3233
UPC0311917217123
Quantity recalled31,872 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0991-2022
FDA event ID
90297
Recalling firm
Grato Holdings, Woodbine, IA
Manufacturer
Walgreen Company
Classification
Class II
Status
Terminated
Recall initiated
24 May 2022
FDA classified
8 Jun 2022
Reported
15 Jun 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

24 May 2022Recall initiated by company
8 Jun 2022Classified by FDA+15 days
15 Jun 2022Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Microbial contamination of non-sterile product.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Earache Drops, 0.33 FL OZ (10 mL) bottles, Distributed by: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015. NDC 0363-3233-15

Where it was distributed

Nationwide within the USA

Nationwide

Questions about this recall

Is Earache Drops recalled?

Yes. Grato Holdings recalled Earache Drops on 24 May 2022. The recall is Class II and its status is Terminated. Recall number D-0991-2022.

Why was it recalled?

Microbial contamination of non-sterile product.

Which lots are affected?

Lot #: G11639, Exp. Date 09/24

Where was it sold?

Nationwide within the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Grato Holdings

All 18